Small Dense LDL: Scientific Background, Clinical Relevance, and Recent Evidence Still a Risk Even with ‘Normal’ LDL-C Levels

Residual cardiovascular disease event risk, following statin use and low-density lipoprotein cholesterol (LDL-C) reduction, remains an important and common medical conundrum. Identifying patients with significant residual risk, despite statin drug use, is an unmet clinical need. One pathophysiologic...

Descripción completa

Detalles Bibliográficos
Autores principales: Superko, Harold, Garrett, Brenda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025822/
https://www.ncbi.nlm.nih.gov/pubmed/35453579
http://dx.doi.org/10.3390/biomedicines10040829

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025822/
https://www.ncbi.nlm.nih.gov/pubmed/35453579
http://dx.doi.org/10.3390/biomedicines10040829

Ejemplares similares